National Cancer Institute SBIR & STTR Deadlines – August 5

NCI bannerNCI Cancer Grant FundingApply Today! Don’t Miss National Cancer Institute
Funding Opportunities for Small Businesses
Next Deadline: August 5, 2013

The Small Business Innovation Research & Small Business Technology Transfer (SBIR & STTR) Programs represent one of the largest sources of early-stage technology financing in the United States. Funding is available to support small businesses working across a wide range of cancer-related research topic areas through the SBIR & STTR Omnibus Solicitation, an investigator-initiated grant funding opportunity. The next deadline to submit applications is August 5, 2013.

All applicants
to the National Cancer Institute (NCI) SBIR & STTR programs must use the re-issued PHS 2013-2 Omnibus Grant Solicitations, PA-13-234 (SBIR) and PA-13-235 (STTR) for the upcoming August 5 and December 5 deadlines. The NCI SBIR & STTR Programs have additional targeted grant funding opportunities available in various topic areas to help small businesses advance their research concepts towards commercialization.

Important Information about the Reissued Omnibus Solicitation

The original SBIR and STTR Omnibus solicitations, PA-13-088 (SBIR) and PA-13-089 (STTR) are now EXPIRED.

  • Applicants will receive an error during submission if these expired funding opportunity announcements (FOAs) are used.
  • Please download and use the ACTIVE re-issued Omnibus Solicitation FOAs (PA-13-234, SBIR and PA-13-235, STTR) for all applications to the remaining due dates. This includes resubmissions (‘-A1s’).

The re-issued 2013 Omnibus Solicitation expands eligibility and impacts the application process, so please read the solicitations carefully. With this re-issue, the NIH SBIR/STTR programs implement the following provisions of the SBIR/STTR Reauthorization Act:

  • Small business concerns that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms are now eligible to apply to the NIH SBIR program and compete for up to 25% of NIH’s SBIR set-aside.
  • All applicants are required to register at the SBA Company Registry prior to application submission and attach proof of registration. See below for the full list of registration requirements for submitting SBIR/STTR applications to HHS.

For further details, please see NIH Guide Notice NOT-OD-13-071 or check the NIH implementation plan website.

To view the official re-issued 2013 SBIR & STTR Omnibus Solicitations, please visit:

SBIR Program
PA-13-234, Re-issue PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Receipt Dates: August 5, 2013; December 5, 2013

STTR Program
PA-13-235
, Re-issue PHS 2013-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
Receipt Dates: August 5, 2013; December 5, 2013

Registration Requirements Prior to Submitting SBIR/STTR Applications to HHS

If you are considering applying for an SBIR/STTR award, check that your registrations are all completed. It is never too early to start the registration process, even if you are thinking about submitting for December 5th or beyond, but especially for August 5th!

Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take six weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.

  • Dun and Bradstreet Universal Numbering System (DUNS) – All registrations require that applicants be issued a DUNS number. After obtaining a DUNS number, applicants can begin SAM, SBA Company, and eRA Commons registrations. The same DUNS number must be used for all registrations, as well as on the grant application.
  • System for Award Management (SAM) (formerly CCR) – Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
  • eRA Commons – Applicants must have an active DUNS number and SAM registration in order to complete the eRA Commons registration. Organizations can register with the eRA Commons as they are working through their SAM or Grants.gov registration. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
  • Grants.gov – Applicants must have an active DUNS number and SAM registration in order to complete the Grants.gov registration.
  • SBA Company RegistryNew requirement. See Section IV. Application and Submission Information, “SF424 (R&R) Other Project Information Component” for instructions on how to register and how to attach proof of registration to your application package. Applicants must have a DUNS number to complete this registration. SBA Company registration is NOT required before SAM, Grants.gov, or eRA Commons registration.

As always, if you have difficulties with the submission process, please contact the eRA Commons helpdesk:

Toll-free: 1-866-504-9552
Phone: 301-402-7469
TTY: 301-451-5939
Email: commons@od.nih.gov
Hours: Mon-Fri, 7 a.m. to 8 p.m. Eastern Time (Except for federal holidays)

Additional Funding Opportunities

The NCI SBIR & STTR Programs have additional grant funding opportunities available in a wide range of cancer-related topic areas. These grants have deadlines of July 8, 2013 and August 5, 2013. Don’t miss your chance to apply!

PAR-10-286, Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology (SBIR U43/U44)
Receipt Date: July 8, 2013

PA-12-196
, Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR R44)
For more details and examples of applicable projects, click here.
Receipt Dates: August 5, 2013; Standard receipt dates (April 5, August 5, December 5) through 2014

PA-13-140, Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR R43/R44)
Receipt Dates: August 5, 2013; Standard receipt dates (April 5, August 5, December 5) through 2015

For a complete listing of funding opportunities from the NCI SBIR & STTR Programs, please click here.

How to Apply
For resources and tips for applying, please click here.

Please visit http://sbir.cancer.gov/ to learn more about the NCI SBIR & STTR Programs.

The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: